SCHEMBL10236348

SCHEMBL10236348

CC(C)(C)c1ccnn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
KCNN4 O15554 2/20 0.35
KCNA3 P22001 2/20 0.35
KMT2A Q03164 3/20 0.35
CYP3A4 P08684 3/20 0.35
MEN1 O00255 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 3/20 0.32
CYP2B6 P20813 1/20 0.32
ALOX15 P16050 2/20 0.31
TAAR1 Q96RJ0 1/20 0.31
CHRM3 P20309 2/20 0.31
SLC22A1 O15245 1/20 0.31
NR1I2 O75469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13189778 0.77 CYP11B1 (0.40) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL6762492 0.76 DRD1 (0.31) KMT2ACYP3A4MEN1CYP1A2CYP2D6
SCHEMBL28999271 0.74 CYP11B1 (0.38) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL15528498 0.73 CYP11B1 (0.40) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL20361855 0.73 CYP11B1 (0.40) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL20360982 0.73 KCNN4 (0.44) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL6923638 0.73 POLB (0.47) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL11523600 0.70 CYP11B1 (0.38) CYP11B1CYP11B2KCNN4KCNA3KMT2A
SCHEMBL13492177 0.69 POLB (0.52) CYP3A4CYP2C19KDM4EATMALDH1A1
SCHEMBL5361990 0.69 CYP11B1 (0.37) CYP11B1CYP11B2KCNN4KCNA3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193372-B2 Phosphothiophene and phosphothiazole HCV polymerase inhibitors IDENIX PHARMACEUTICALS, INC. (US) 2012-06-05 US disclosed
US-20100233123-A1 PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233123-A1 PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS PPP3CB, POLR2E, PSAT1 CYP11B1 1848/4885CYP11B2 2354/4885KCNN4 3898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.